Article Information
History
- January 25, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Marlies Bode1,2,*,
- Georg Rudolf Herrnstadt1,*,
- Leonie Dreher1,
- Nicolas Ehnert1,
- Pia Kirkerup1,
- Maja T. Lindenmeyer1,2,
- Catherine Meyer-Schwesinger2,3,
- Heimo Ehmke3,
- Jörg Köhl4,
- Tobias B. Huber1,2,
- Thorsten Wiech2,5 and
- Ulrich O. Wenzel1,2,#
- 1III. Department of Medicine, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA
- 2Hamburg Center for Kidney Health (HCKH), University Medical Center Hamburg-Eppendorf, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA
- 3Department of Cellular and Integrative Physiology University Hospital Hamburg-Eppendorf, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA
- 4Institute for Systemic Inflammation Research, Lübeck, Germany, and Division of Immunobiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA
- 5Department of Pathology, Section of Nephropathology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
- ↵#Correspondence to: Ulrich Wenzel, III. Department of Medicine, University Hospital Hamburg-Eppendorf Martinistr. 52; 20246 Hamburg, Germany, Phone: +4940741050062, Fax: +4940741055186, Mail: wenzel{at}uke.de
↵* M.B. and G.R.H. contributed equally.
Posted January 25, 2023.
Deficiency of complement C3a and C5a receptors does not prevent angiotensin II–induced hypertension and hypertensive end-organ damage
